The Effects of Acceptance and Commitment Therapy on Psychosocial Impact and Adherence of MDR-TB Patients

Overview

Journal J Public Health Res

Publisher Sage Publications

Specialty Public Health

Date 2022 Mar 4

PMID 35244358

Authors

Priyo Purnomo Ashab

Budi Anna Keliat

Ice Yulia Wardani

Affiliations

Soon will be listed here.

Abstract

Background: The Worldwide resistance prevalence of the first-line TB drug, rifampicin (RR-TB), in 2017 was 7.4 per 100,000 population, and 82% of them experienced multidrug-resistant tuberculosis (MDR-TB). Indonesia is the top 20 country with an MDR-TB burden, and its prevalence is 8.8 per 100,000 population. MDR-TB requires a long-time treatment and has accompanying side effects: biological and psychosocial effects. However, efforts to overcome the psychosocial impacts have not been conducted. This study aims to determine the effect of acceptance and commitment therapy (ACT) on anxiety, depression, suicidal ideation, and treatment adherence in MDR-TB patients.

Design And Methods: This research employed a quasi-experimental design with a pre-test three post-tests using total sampling. The pre-test was conducted before the standard nursing intervention, post-test 1 was after the standard nursing intervention, post-test 2 was after ACT session 1, and post-test 3 was after ACT session 2. Data were collected by the Hamilton Rating Scale for Anxiety (HAM-A), Beck Hopelessness Scale (BHS), a Scale for Suicide Ideation (SSI), and Morisky Medication Adherence Scale (MMAS).

Results: The standard nursing action and ACT reduce anxiety (p = 0.002), reduced depression (p = 0.0001), reduced suicidal ideation (p = 0.008), and increased treatment adherence (p = 0.0001).

Conclusions: The standard nursing action and ACT reduce anxiety, depression, and suicidal ideation. They increase treatment adherence recommended for use in MDR-TB patients.

Citing Articles

The effectiveness of acceptance and commitment therapy on clinical symptoms and treatment adherence in dialysis patients.

Sadeghi A, Ahmadi S, Ghodrati-Torbati A J Educ Health Promot. 2024; 13:28.

PMID: 38545310 PMC: 10967931. DOI: 10.4103/jehp.jehp_1704_22.

The Effect of a Group-Based Mindfulness and Acceptance Training on Psychological Flexibility and Adherence to Antiretroviral Therapy Among Adolescents in Uganda: An Open-Label Randomized Trial.

Musanje K, Kamya M, Kasujja R, Vanderplasschen W, Sinclair D, Baluku M J Int Assoc Provid AIDS Care. 2024; 23:23259582241236260.

PMID: 38446992 PMC: 10919136. DOI: 10.1177/23259582241236260.

Can a practical process-oriented strategy prevent suicidal ideation and behavior?.

Hayes S, Pistorello J World Psychiatry. 2024; 23(1):154-155.

PMID: 38214625 PMC: 10785979. DOI: 10.1002/wps.21158.

Characterising and Addressing the Psychosocial Impact of Tuberculosis in Indonesia (CAPITA): A study protocol.

Fuady A, Fitriangga A, Sugiharto A, Arifin B, Yunita F, Yani F Wellcome Open Res. 2023; 7:42.

PMID: 36874576 PMC: 9975400. DOI: 10.12688/wellcomeopenres.17645.2.

References

Huque R, Elsey H, Fieroze F, Hicks J, Huque S, Bhawmik P . "Death is a better option than being treated like this": a prevalence survey and qualitative study of depression among multi-drug resistant tuberculosis in-patients. BMC Public Health. 2020; 20(1):848. PMC: 7268321. DOI: 10.1186/s12889-020-08986-x. View

Khanal S, Elsey H, King R, Baral S, Bhatta B, Newell J . Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal. PLoS One. 2017; 12(1):e0167559. PMC: 5242498. DOI: 10.1371/journal.pone.0167559. View

Alene K, Clements A, McBryde E, Jaramillo E, Lonnroth K, Shaweno D . Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis. J Infect. 2018; 77(5):357-367. DOI: 10.1016/j.jinf.2018.07.007. View

Ruiz-Grosso P, Cachay R, de la Flor A, Schwalb A, Ugarte-Gil C . Association between tuberculosis and depression on negative outcomes of tuberculosis treatment: A systematic review and meta-analysis. PLoS One. 2020; 15(1):e0227472. PMC: 6953784. DOI: 10.1371/journal.pone.0227472. View

Watts K . MDR-TB, Isolation, and Anomie: Has Anyone Referred to Social Work? : Comment on "The Ethics of Isolation for Patients With Tuberculosis in Australia". J Bioeth Inq. 2016; 13(1):157-8. DOI: 10.1007/s11673-016-9707-3. View

Coto-Lesmes R, Fernandez-Rodriguez C, Gonzalez-Fernandez S . Acceptance and Commitment Therapy in group format for anxiety and depression. A systematic review. J Affect Disord. 2019; 263:107-120. DOI: 10.1016/j.jad.2019.11.154. View

Ducasse D, Jaussent I, Arpon-Brand V, Vienot M, Laglaoui C, Beziat S . Acceptance and Commitment Therapy for the Management of Suicidal Patients: A Randomized Controlled Trial. Psychother Psychosom. 2018; 87(4):211-222. DOI: 10.1159/000488715. View

Hacker T, Stone P, MacBeth A . Acceptance and commitment therapy - Do we know enough? Cumulative and sequential meta-analyses of randomized controlled trials. J Affect Disord. 2015; 190:551-565. DOI: 10.1016/j.jad.2015.10.053. View

Pots W, Fledderus M, Meulenbeek P, Ten Klooster P, Schreurs K, Bohlmeijer E . Acceptance and commitment therapy as a web-based intervention for depressive symptoms: randomised controlled trial. Br J Psychiatry. 2015; 208(1):69-77. DOI: 10.1192/bjp.bp.114.146068. View

10.

Belanger A, Morris S, Brostrom R, Yost D, Goswami N, Oxtoby M . Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States. J Clin Tuberc Other Mycobact Dis. 2019; 15:100090. PMC: 6830138. DOI: 10.1016/j.jctube.2019.01.005. View

11.

Graham C, Gouick J, Krahe C, Gillanders D . A systematic review of the use of Acceptance and Commitment Therapy (ACT) in chronic disease and long-term conditions. Clin Psychol Rev. 2016; 46:46-58. DOI: 10.1016/j.cpr.2016.04.009. View

12.

Ducasse D, Rene E, Beziat S, Guillaume S, Courtet P, Olie E . Acceptance and commitment therapy for management of suicidal patients: a pilot study. Psychother Psychosom. 2014; 83(6):374-6. DOI: 10.1159/000365974. View

13.

Furin J, Loveday M, Hlangu S, Dickson-Hall L, Le Roux S, Nicol M . "A very humiliating illness": a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa. BMC Public Health. 2020; 20(1):76. PMC: 6969445. DOI: 10.1186/s12889-019-8035-z. View

14.

Dela A, Tank N, Singh A, Piparva K . Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study. Lung India. 2017; 34(6):522-526. PMC: 5684809. DOI: 10.4103/0970-2113.217569. View

15.

Deshmukh R, Dhande D, Sachdeva K, Sreenivas A, Kumar A, Satyanarayana S . Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India. PLoS One. 2015; 10(8):e0135802. PMC: 4547708. DOI: 10.1371/journal.pone.0135802. View

16.

Twohig M, Levin M . Acceptance and Commitment Therapy as a Treatment for Anxiety and Depression: A Review. Psychiatr Clin North Am. 2017; 40(4):751-770. DOI: 10.1016/j.psc.2017.08.009. View

17.

Vernon A, Fielding K, Savic R, Dodd L, Nahid P . The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials. PLoS Med. 2019; 16(12):e1002884. PMC: 6903706. DOI: 10.1371/journal.pmed.1002884. View

18.

A-Tjak J, Morina N, Topper M, Emmelkamp P . A Randomized Controlled Trial in Routine Clinical Practice Comparing Acceptance and Commitment Therapy with Cognitive Behavioral Therapy for the Treatment of Major Depressive Disorder. Psychother Psychosom. 2018; 87(3):154-163. DOI: 10.1159/000486807. View

19.

Walker I, Kanal S, Baral S, Farragher T, Joshi D, Elsey H . Depression and anxiety in patients with multidrug-resistant tuberculosis in Nepal: an observational study. Public Health Action. 2019; 9(1):42-48. PMC: 6436490. DOI: 10.5588/pha.18.0047. View

20.

Limenih Y, Workie D . Survival analysis of time to cure on multi-drug resistance tuberculosis patients in Amhara region, Ethiopia. BMC Public Health. 2019; 19(1):165. PMC: 6367739. DOI: 10.1186/s12889-019-6500-3. View